How many employees does Acer Pharma Limited have?

Acer Pharma Limited reported an average of 2 employees in the year to 30 Apr 2025.

Is Acer Pharma Limited profitable?

Yes — Acer Pharma Limited reported a profit of £289k in the year to 30 Apr 2025.

Company No. 10045381 · Incorporated 7 Mar 2016

Acer Pharma Limited

Registered name: ACER PHARMA LIMITED

Part of CST Pharma Holdings Limited group

Acer Pharma Limited made £289k profit in the year to 30 Apr 2025 (revenue not disclosed).

Acer Pharma Limited reported £289k profit in the year to 30 Apr 2025; its revenue was not disclosed. It had 2 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Walsall; we hold 4 years of its filed accounts.

Profit onlySection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Walsall, West Midlands
Age: 10 yrs · since 2016
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The ultimate”

Latest accounts · year to 30 Apr 2025

Key figures

Small team

Revenue

—

Not disclosed in filing

Profit

£289k

Growth —

Profit margin

—

Employees

Change 0%

Profit / employee

£145k

Profitable streak

1yr

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024	30 Apr 2025
Disclosure	Profit only	Profit only	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—	—
Profit after tax	−£66.7k	£0	−£1.3m	£289k
Profit (best available)	−£66.7k	£0	−£1.3m	£289k
Employees (average)	0	0	2	2
Ratios
Profit margin	—	—	—	—
Profit per employee	—	—	−£633k	£145k
Growth (year on year)
Headcount growth	—	—	—	0%
Balance sheet — indirect signals, not revenue
Cash at bank	£3.4k	£2.7k	£3.2k	£0
Net assets	£3.7m	£3.7m	£2.4m	£2.7m
Current assets	£3.3m	£2.4m	£3.2m	£6.1m
Debtors	£1.6m	£713k	£80.2k	£1.2m
Source	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: £145k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲12%; Now £2.7m
Cash at bank: ▼100%; Now £0
Headcount: 0%; Now 2
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

CST Pharma Holdings Limitedultimate parent75–100%
C.S.T. Pharma Group Holdings Limited75–100%
Acer Pharma Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

C. S. T. Pharma LimitedRev. £91.3m · Profit £1.7m
Curagenix Life Sciences LimitedFigures not disclosed
MPT Pharma LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Apr 2025 (profit £289k), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.